Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia

• Oussama ElMokh,
• Saki Matsumoto,
• Paulina Biniecka,
• Axel Bellotti,
• Karin Schaeuble,
• Francesco Piacente,
• Hector Gallart-Ayala,
• Julijana Ivanisevic,
• Ivan Stamenkovic,
• Alessio Nencioni,
• Aimable Nahimana,
• Michel A. Duchosal

Affiliations

Oussama ElMokh

Central Laboratory of Hematology, Department of Medical Laboratory and Pathology, Lausanne University Hospital and University of Lausanne

Saki Matsumoto

Central Laboratory of Hematology, Department of Medical Laboratory and Pathology, Lausanne University Hospital and University of Lausanne

Paulina Biniecka

Central Laboratory of Hematology, Department of Medical Laboratory and Pathology, Lausanne University Hospital and University of Lausanne

Axel Bellotti

Central Laboratory of Hematology, Department of Medical Laboratory and Pathology, Lausanne University Hospital and University of Lausanne

Karin Schaeuble

Department of Oncology UNIL CHUV, University of Lausanne

Francesco Piacente

Department of Internal Medicine, University of Genoa

Hector Gallart-Ayala

Metabolomics Unit, Faculty of Biology and Medicine, University of Lausanne

Julijana Ivanisevic

Metabolomics Unit, Faculty of Biology and Medicine, University of Lausanne

Ivan Stamenkovic

Department of Formation and Research, Lausanne University Hospital and University of Lausanne

Alessio Nencioni

Department of Internal Medicine, University of Genoa

Aimable Nahimana

Central Laboratory of Hematology, Department of Medical Laboratory and Pathology, Lausanne University Hospital and University of Lausanne

Michel A. Duchosal

Central Laboratory of Hematology, Department of Medical Laboratory and Pathology, Lausanne University Hospital and University of Lausanne